Literature DB >> 12640682

Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation.

Marine Gross-Goupil1, Philippe Riou, Jean-François Emile, Raphaël Saffroy, Daniel Azoulay, Isabelle Lacherade, Aline Receveur, Dominique Piatier-Tonneau, Denis Castaing, Brigitte Debuire, Antoinette Lemoine.   

Abstract

To investigate the genetic mechanism of metastatic spread in hepatocellular carcinoma (HCC), we analyzed genomic changes in lung or liver metastases and the corresponding primary tumors (83 tumor samples) in 18 patients who underwent orthotopic liver transplantation. We studied the incidence of microsatellite instability (MSI) and loss of heterozygosity (LOH) involving 8 highly polymorphic microsatellite markers and the polyA tract, Bat26. We also sought alterations of p53 and beta-catenin gene mutations. High MSI (>30-40% of the loci analyzed) was found only in primary tumors (11%), whereas LOH was observed in 50% of primary and in 39% of recurrent tumors. p53 mutations were found in 2 cases of primary HCC but not in the corresponding metastases. P53 was overexpressed in 4 primary HCC (22%) and 7 metastases (39%). The percentage of beta-catenin gene mutations was low (6%). Lung metastases retained the D16S402 microsatellite abnormalities observed in the primary tumors, whereas recurrent liver tumor did not (p = 0.02). In conclusion, LOH and P53 protein overexpression, rather than mutations in the p53 or beta-catenin genes or MSI, seem to be involved in the spreading of HCC, suggesting the presence of metastasis suppressor genes in the vicinity of the chromosomal loci in question. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640682     DOI: 10.1002/ijc.11017

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Low Levels of Microsatellite Instability at Simple Repeated Sequences Commonly Occur in Human Hepatocellular Carcinoma.

Authors:  Claire Goumard; Christele Desbois-Mouthon; Dominique Wendum; Claire Calmel; Fatiha Merabtene; Olivier Scatton; Françoise Praz
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

2.  Differentially expressed genes between early and advanced hepatocellular carcinoma (HCC) as a potential tool for selecting liver transplant recipients.

Authors:  Valeria R Mas; Daniel G Maluf; Kellie J Archer; Kenneth Yanek; Bridgette Williams; Robert A Fisher
Journal:  Mol Med       Date:  2006 Apr-Jun       Impact factor: 6.354

Review 3.  Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers.

Authors:  Masahiro Fujimuro; S Diane Hayward
Journal:  J Mol Med (Berl)       Date:  2004-01-09       Impact factor: 4.599

Review 4.  Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics.

Authors:  Rocio I R Macias; Maria J Monte; Maria A Serrano; Jesús M González-Santiago; Isabel Martín-Arribas; André L Simão; Rui E Castro; Javier González-Gallego; José L Mauriz; Jose J G Marin
Journal:  Aging (Albany NY)       Date:  2021-10-11       Impact factor: 5.682

5.  Metallophosphoesterase 1, a novel candidate gene in hepatocellular carcinoma malignancy and recurrence.

Authors:  Xinguo Chen; Jing Xu; Peixiao Wang; Lei Shang; Jing Guo; Lihong Huang; Yide A Jiang; Jinhong Chen; Huijuan Chen; Yukui Shang; Qing Zhang
Journal:  Cancer Biol Ther       Date:  2020-10-15       Impact factor: 4.742

6.  Selective Retention of an Inactive Allele of the DKK2 Tumor Suppressor Gene in Hepatocellular Carcinoma.

Authors:  Yung-Feng Lin; Ling-Hui Li; Chih-Hung Lin; Mei-Hua Tsou; Ming-Tai Kiffer Chuang; Keh-Ming Wu; Tsai-Lien Liao; Jian-Chiuan Li; Wei-Jie Wang; Angela Tomita; Beverly Tomita; Shiu-Feng Huang; Shih-Feng Tsai
Journal:  PLoS Genet       Date:  2016-05-20       Impact factor: 5.917

7.  Immunohistochemical Determination of p53 Protein Overexpression for Predicting p53 Gene Mutations in Hepatocellular Carcinoma: A Meta-Analysis.

Authors:  Jiangbo Liu; Wei Li; Miao Deng; Dechun Liu; Qingyong Ma; Xiaoshan Feng
Journal:  PLoS One       Date:  2016-07-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.